MENU
+Compare
REPL
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$10.09
Change
+$0.37 (+3.81%)
Capitalization
791.49M

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for REPL with price predictions
Dec 24, 2025

Momentum Indicator for REPL turns positive, indicating new upward trend

REPL saw its Momentum Indicator move above the 0 level on December 24, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where REPL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for REPL moved above the 200-day moving average on December 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REPL advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where REPL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for REPL moved out of overbought territory on December 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for REPL turned negative on December 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REPL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

REPL broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.006) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. REPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 15.01% to -76 cents per share on February 11

Replimune Group REPL Stock Earnings Reports
Q4'25
Est.
$-0.76
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.11
Q1'25
Missed
by $2.35
Q4'24
Missed
by $0.03
The last earnings report on November 06 showed earnings per share of -89 cents, missing the estimate of -77 cents. With 607.05K shares outstanding, the current market capitalization sits at 791.49M.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMEGX22.090.10
+0.45%
Nomura Systematic Emerging Markets Eq R6
RYHCX95.600.33
+0.35%
Rydex Health Care C
BGSRX69.760.13
+0.19%
BlackRock Technology Opportunities R
BLYYX35.010.05
+0.14%
American Beacon Man Lg Cp Growth Y
FJACX11.18N/A
N/A
Fidelity Series Small Cap Discovery

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with NEVPF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+3.81%
NEVPF - REPL
64%
Loosely correlated
N/A
ELVAF - REPL
60%
Loosely correlated
N/A
IMNN - REPL
57%
Loosely correlated
-7.80%
SNDX - REPL
49%
Loosely correlated
-0.46%
KYMR - REPL
45%
Loosely correlated
-0.48%
More